Type 1 Diabetes Trial, Recruiting NCT07666789 Sponsor: University Hospital, Montpellier Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT07666789
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with type 1 diabetes
  • People who have previously received a beta-cell replacement treatment, either an islet transplant or a pancreas transplant
  • People whose islet re-transplant (a second or repeat islet transplant) was performed after 2005
  • People who received their islet re-transplant after their first transplant was confirmed to have failed, meaning either C-peptide levels (a marker of insulin production) were undetectable or severe low blood sugar episodes returned while back on insulin therapy
  • People for whom the necessary medical and test result records are available to assess the study outcomes

Who may not be able to join:

  • People whose medical records are missing or incomplete in a way that would prevent the main study outcome from being assessed
  • People who do not meet the inclusion criteria listed above

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 467 338 382

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
31 July 2025
Est. completion
30 September 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Islet graft success

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov